For the past three decades, cancer is the number one cause of death in Taiwan. An increasing trend in the incidence of urologic cancers has also been noticed since 1979. In 2012, urologic cancer accounted for 10.
0% of all the new malignant cases. Prostate, bladder and kidney cancers are the most common types. Metastatic prostate cancer still accounted for nearly 30% of new cases in Taiwan between 2004 and 2012. There are several specifically noticeable characteristics of urothelial carcinoma in Taiwan, associated with arseniasis and aristolochic acid. The diagnosis and treatment of urologic cancer mainly follows the current international guidelines. The development of minimal invasive surgery, especially DaVinci robotic surgical system, has made a marked change in the surgical treatment of urologic cancer. Meanwhile, newer systemic agents also commence and improve our standard of care. However, treatment decisions are greatly influenced by the National Health Insurance coverage. The current national cancer registry system should be renovated more comprehensively in order to gain better insight into specific features of urologic cancer in Taiwan.
Japanese journal of clinical oncology. 2016 Apr 06 [Epub ahead of print]
Chi-Feng Hung, Cheng-Kuang Yang, Yen-Chuan Ou
Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung., Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung., Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan